Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Post by Atomekon Nov 19, 2015 9:05am

139 Views

Post# 24304530

Short Sales OTCQX International

PFSCF

ProMetic Life Sciences Inc.

Ordinary Shares International Reporting

OTCQX International OTCQX Advisor: Ladenburg Thalmann & Co. Inc.

2.200.0568 (2.65%) at Nov 18, 2015

Real-Time Best Bid & Ask

2.21 / 2.23 (200 x 200)

Short Sales


Oct 30, 2015	6,879,189	6.59	60,214	114.25	No	No
Oct 15, 2015	6,454,058	18.49	57,341	112.56	No	No
Sept 30, 2015	5,446,696	11.80	44,694	121.87	No	No
Sept 15, 2015	4,871,853	4.00	13,454	362.11	No	No
Aug 31, 2015	4,684,457	6.44	41,401	113.15	No	No
Aug 14, 2015	4,401,056	12.11	22,741	193.53	No	No
Jul 31, 2015	3,925,517	-5.42	26,139	150.18	No	No